Rafael Nadal tests positive for Covid-19 on return to Spain. Can still play in Oz though. https://www.bbc.co.uk/sport/tennis/59726728
There's an interesting story from the US about Ivermectin. The Health insurance companies have sent communications to the doctors on their panels to cease from prescribing Ivermectin even off label, which means unathourised use but remains perfectly legal if safe to use. Now this breaches the terms and conditions that the Health Insurance have with the doctors. Their licence and agreement with the doctors states that they will not interfere with the doctor patient relationship including the prescribing of drugs. They have unilaterally altered the terms and condtions to say "except for the prescription of ivermectin". If they find out that the doctor has subsequently prescribed Ivermectin then they risk sanctions including exclusion. Now the new kid on the block is Pfizer's Paxlovid, which is two drugs, nirmatrelvir and ritonavir, The dose is 3 pills for 5 days. The eye watering costs is 700 dollars a dose. Paxlovid is a protease inhibitor and is patented by Pfizer which will last 20 years. Its been rushed through approval by the FDA. Its use is for those suffering symptoms but before hospitilisation within 5 days. Ivermectin is cheap. The patent from Pfizer has run out. There is so much misinformation about this drug. E.g. anti parasite for animals but it has been used millions of times in humans for treatment of scabies. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996102/ Conclusion Developing an effective therapeutic against COVID-19 is currently the utmost interest to the scientific communities. The present study depicts comparative binding efficacy of a promising FDA-approved drug, ivermectin, against major pathogenic proteins of SARS-CoV-2 and their human counterparts involved in host–pathogen interaction. Herein, our in silico data have indicated that ivermectin efficiently utilizes viral spike protein, main protease, replicase and human TMPRSS2 receptors as the most possible targets for executing its antiviral efficiency. Therefore, ivermectin exploits protein targets from both virus and human, which could be the reason behind its excellent in vitro efficacy against SARS-CoV-2 as reported by Caly et al. [13]. Ivermectin B1b isomers have been found to be the more efficacious molecule out of the two homologs. Intriguingly, comparison of the in silico efficiency of ivermectin with currently used anticorona drugs, such as hydroxychloroquine and remdesivir, indicated toward the potential of ivermectin to target the major pathogenic proteins of SARS-CoV-2. Ivermectin is a popular antiparasitic drug and is also safe in children, younger adults, pregnant and lactating ladies. Development of pulmonary delivery of ivermectin through synthesis of better ivermectin formulation has been reported recently and this is expected to shorten the treatment duration and lead to better outcomes [33]. It is noteworthy to mention that many anti-SARS-CoV-2s are now being tested for their efficacy in shaping the immune response of humans, through targeting the cell surface as well as intracellular toll-like receptors [34,35]. In this context, ivermectin could be an effective option as well. Considering all these facts, the present study explores the therapeutic targets of ivermectin against SARS-CoV-2 and enlightens the possibility of using this drug in COVID-19 clinical trials shortly.
https://dailyexpose.uk/2022/01/14/triple-jabbed-account-for-4-in-5-covid-deaths/ Triple/Double Vaccinated account for 4 in every 5 Covid-19 Cases, Hospitalisations & Deaths since November according to official figures 80%
Are you predicting that you will die masturbating but they will not discover your corpse for a couple of days?
